Company: NDRA
Filing Date: 2025-10-17
Form Type: PRE 14A
Source: 0001654954-25-011931
Chunk: 43

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-10-17
Form: PRE 14A
Chunk 43
---
 shares of common stock are available for potential future corporate purposes. An increase in the number of authorized shares of our common stock enables us to have a sufficient number of shares of common stock available for a variety of possible future corporate purposes, including but not limited to issuing stock under existing equity compensation plans, stock dividends or stock splits, and possible future acquisitions. |
| · | Enabling equity transactions to raise additional capital. The availability of additional shares of our common stock will permit us to raise capital through equity transactions. Any such additional capital may be used to fund the Company’s digital asset treasury operations and the accumulation of cryptocurrency. However, we have no plans, arrangements, or understandings for any such equity transactions at this time.                                           |

The newly authorized shares of common stock would have the same rights as the currently outstanding shares of our common stock. As of October 16, 2025:

| · | 1,166,441 shares of our common stock were issued and outstanding;                                                                                                                              |
| · | 364,801 shares of our common stock were issuable upon the exercise of outstanding prefunded warrants issued in the private placement consummated on October 15, 2025;                          |
| · | 1,669,387 shares of our common stock were issuable upon the exercise of outstanding warrants;                                                                                                  |
| · | 1 share of our common stock were issuable upon the conversion of outstanding shares of Series A Preferred Stock, including shares issuable in respect of accrued and unpaid dividends thereon; |
| · | 266 shares of our common stock were issuable upon the exercise of outstanding stock options issued pursuant to the 2016 Plan;                                                                  |
| · | 147,169 shares of our common stock were issuable upon the exercise of outstanding RSUs issued pursuant to the 2016 Plan; and                                                                   |
| · | 32,336 shares of our common stock were reserved for future issuance under the 2016 Plan.                                                                                                       |

Accordingly, 3,348,065 of the 20,000,000 currently authorized shares of our common stock are issued or reserved for issuance, while 16,651,935 of the 20,000,000 currently authorized shares of our common stock otherwise remain available for future issuance.

| 33 |

Implementation of the Authorized Share Increase

Following stockholder approval of this proposal, the increase in authorized shares of common stock would be implemented by our filing the Increase in Authorized Shares Certificate of Amendment with the Secretary of State of the State of